港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

高瓴概念

510.843

-19.317-3.64%

漲家數：8

跌家數：43

平家數：4

市盈率：- -

高：530.970

開：530.107

低：506.286

收：530.160

資料載入中...

“全鏈”代幣化平台Libre將貝萊德、野村等機構資金引入L1網絡Injective

Bitwise通過Maple Finance完成首筆機構級DeFi投資

代幣化資產管理公司Superstate在美SEC註冊為轉賬代理商

Bitwise通過Maple Finance完成首筆機構級DeFi投資

Bitwise通過Maple Finance完成首筆機構級DeFi投資

《盈警》心通醫療(02160.HK)虧損大減全年最多蝕6,000萬人民幣

阿斯达克财经

滙豐：歐洲央行漸進降息或提振風險資產

醫療健康行業：心臟瓣膜：行業呈現回暖趨勢

中国国际金融股...

京東健康去年盈利超41億元，復旦復華終止收購美麗人生，復星醫藥1類新藥報產，恆瑞醫藥1類新藥獲批臨牀

滙豐：歐洲央行漸進降息或提振風險資產

機構：歐洲央行可能已非常接近中性利率

和黃醫藥(00013.HK)HMPL-453治療肝內膽管癌II期臨牀試驗已完成患者入組

阿斯达克财经

百濟神州授出合共3.26萬股受限制股份單位

百濟神州(06160)授出購股權及受限制股份單位

百濟神州(06160.HK)授出合共3.26萬股受限制股份單位

中紅醫療：子公司獲得醫療器械註冊證

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1583/news?page=16"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","market":"HK","secType":"PLATE","nameCN":"高瓴概念","latestPrice":510.84283,"timestamp":1741594084374,"preClose":530.16,"halted":0,"volume":641110353,"delay":0,"changeRate":-0.036436,"change":-19.317139,"pbRate":2.561308,"amount":16897837474.6,"amplitude":0.04656,"prevYearClose":446.93042,"fiveDayClose":491.838,"twentyDayClose":478.478,"turnoverRate":0.004545,"marketCap":2846829146368,"floatMarketCap":2260124340224,"peRate":34.961436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1583\",,,,,undefined,":{"symbol":"BK1583","high":530.9704,"amplitude":0.04656,"preClose":530.16,"low":506.28616,"pbRate":"2.561308","latestPrice":510.84283,"volume":641110353,"delay":0,"open":530.1071,"prevYearClose":446.93042,"prevWeekClose":530.16,"prevMonthClose":492.906,"prevQuarterClose":446.93,"fiveDayClose":491.838,"twentyDayClose":478.478,"sixtyDayClose":472.845,"secType":"PLATE","market":"HK","turnoverRate":0.004545,"peRate":34.961436,"marketCap":2846829146368,"floatMarketCap":2260124340224,"timestamp":1741594084374,"nameCN":"高瓴概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1583\",,,,undefined,":{"bkCode":"BK1583","up":8,"down":43,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1583\",pageSize:16,pageCount:16,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517766197","title":"“全鏈”代幣化平台Libre將貝萊德、野村等機構資金引入L1網絡Injective","url":"https://stock-news.laohu8.com/highlight/detail?id=2517766197","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517766197?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 04:26","pubTimestamp":1741292784,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblock.co/post/345029/omnichain-tokenization-libre-institutional-funds-blackrock-nomura-injective","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["ETH","LU2264538146.SGD","FETH","03046","09009","LU1481011671.HKD","LU1074936037.SGD","LU1988902786.USD","LU0648001328.SGD","ETH.USD.HKCC","09046","ETHW","LU1064131342.USD","ATOM.USD.HKCC","EZET","03179","LU0731783394.SGD","NEAR","BK4588","BLK","LU1509826696.USD","LU1670628061.USD","ETH.USD.CC","161027","SOL.USD.HKCC","IE00B3PB1722.GBP","ETHA","09179","BK1611","03009","BK4567","IE00BDGV0183.EUR","09983","OP.USD.HKCC","QETH","CETH","LU1201861249.SGD","BK4135","LU1989771016.USD","ETHV","IE00BVYPNW00.USD","ETHE","BK1583","LU0070302665.USD","IBIT","LU1291159041.SGD","BK4535","LDO.USD.HKCC","LU0130102774.USD"],"gpt_icon":0},{"id":"2517198460","title":"Bitwise通過Maple Finance完成首筆機構級DeFi投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198460","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517198460?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 01:18","pubTimestamp":1741281498,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/maplefinance/status/1897648536579424284","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["09983","BK1542","BK1258","BK1229","BK1583"],"gpt_icon":0},{"id":"2517198110","title":"代幣化資產管理公司Superstate在美SEC註冊為轉賬代理商","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198110","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517198110?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 01:16","pubTimestamp":1741281384,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.coindesk.com/business/2025/03/06/tokenized-asset-manager-superstate-registers-transfer-agent-with-sec?utm_campaign=coindesk_main&utm_term=organic&utm_source=twitter&utm_content=editorial&utm_medium=social","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK1583","161027","BK1229","09983","BK1542","BK1258"],"gpt_icon":0},{"id":"2517954121","title":"Bitwise通過Maple Finance完成首筆機構級DeFi投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2517954121","media":"世链财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517954121?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 00:45","pubTimestamp":1741279500,"startTime":"0","endTime":"0","summary":"3 月 7 日，据官方消息，Maple Finance 宣布，加密资产管理公司 Bitwise Asset Management 已通过 Maple 完成其首笔机构级 DeFi 投资。Maple 表示，此次合作标志着机构投资者对链上信贷接受度的重大突破，推动 DeFi 迈向更加透明、结构化、具备收益","market":"us","thumbnail":"https://m.shilian.com/assets/addons/cms/img/noimage/112.jpg","type":0,"news_type":0,"thumbnails":["https://m.shilian.com/assets/addons/cms/img/noimage/112.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.shilian.com//kuaixun/788009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"shilian_live","symbols":["BK1583","09983","BK1229","BK1258","BK1542"],"gpt_icon":0},{"id":"2517160535","title":"Bitwise通過Maple Finance完成首筆機構級DeFi投資","url":"https://stock-news.laohu8.com/highlight/detail?id=2517160535","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517160535?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 00:45","pubTimestamp":1741279500,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/284469","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK1542","BK1583","BK1229","09983","BK1258"],"gpt_icon":0},{"id":"2517724167","title":"《盈警》心通醫療(02160.HK)虧損大減  全年最多蝕6,000萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2517724167","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517724167?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 00:36","pubTimestamp":1741278960,"startTime":"0","endTime":"0","summary":"心通医疗－Ｂ发盈警，预计2024年度亏损介乎3,000万至6,000万人民币，较2023年度减少87%-94%。(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2024/08/28中期业绩无派息2024/03/27末期业绩无派息2023/08/29中期业绩无派息2023/03/29末期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220906143936150_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220906143936150_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422812/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1100","02160","BK1574","BK1583"],"gpt_icon":0},{"id":"2517167858","title":"滙豐：歐洲央行漸進降息或提振風險資產","url":"https://stock-news.laohu8.com/highlight/detail?id=2517167858","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517167858?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 00:20","pubTimestamp":1741278038,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d6184e4d27e8e91b8b00e52597fd1b8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash.jin10.com/detail/20250306231354885800","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4588","BK4585","LU1267930227.SGD","LU0128525689.USD","BK1583","BK1229","HSBC","BK1258","BK4207","HK0000934320.USD","LU0052756011.USD","LU0310800965.SGD","BK1542","BK4521","09983","LU2236285917.USD"],"gpt_icon":0},{"id":"2517148477","title":"醫療健康行業：心臟瓣膜：行業呈現回暖趨勢","url":"https://stock-news.laohu8.com/highlight/detail?id=2517148477","media":"中国国际金融股...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517148477?lang=zh_tw&edition=fundamental","pubTime":"2025-03-07 00:00","pubTimestamp":1741276800,"startTime":"0","endTime":"0","summary":"行业近况心通医疗关联企业4C Medical完成D轮融资，中国相关瓣膜资产交易事件频发；中国瓣膜手术量呈现良好增长态势。且瓣膜头部企业心通医疗、沛嘉医疗等，2024 年以来均呈现较为明显的控费减亏趋势。我们认为瓣膜行业后续有望维持良好增速，并持续实现盈利改善。风险竞争格局恶化，行业增速不及预期，集采降价超预期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307082936989f235c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307082936989f235c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","02160","BK1583","BK1574"],"gpt_icon":0},{"id":"2517199543","title":"京東健康去年盈利超41億元，復旦復華終止收購美麗人生，復星醫藥1類新藥報產，恆瑞醫藥1類新藥獲批臨牀","url":"https://stock-news.laohu8.com/highlight/detail?id=2517199543","media":"谈医说药","labels":["productRelease","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517199543?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:38","pubTimestamp":1741275504,"startTime":"0","endTime":"0","summary":"截至公告披露日，申劲锋未持有公司股份。复旦复华：公司决定终止收购宁波美丽人生医药生物科技发展有限公司51%股权。终止原因是上国仲认为案涉《股权收购协议》已经成立但尚未生效。该原料药用于治疗高血压症，浙江新赛科于2023年8月15日提交上市申请，2025年3月5日获得批准。归属于上市公司股东的净利润1.93亿元，同比增长9.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022303abebaf89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022303abebaf89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1571","86618","02196","BK1593","LU0456827905.SGD","BK1589","BK1591","BK1191","LU0051755006.USD","BK1142","06618","600196","BK1247","BK1583"],"gpt_icon":0},{"id":"2517169950","title":"滙豐：歐洲央行漸進降息或提振風險資產","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169950","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169950?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:13","pubTimestamp":1741274034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d6184e4d27e8e91b8b00e52597fd1b8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1258","BK4207","LU0310800965.SGD","LU0128525689.USD","HSBC","BK1229","BK4521","BK1542","LU1267930227.SGD","LU2236285917.USD","BK4585","09983","BK4588","HK0000934320.USD","LU0052756011.USD","BK1583"],"gpt_icon":0},{"id":"2517169988","title":"機構：歐洲央行可能已非常接近中性利率","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169988","media":"金十财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169988?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:10","pubTimestamp":1741273822,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://flash-api.jin10.com/get_flash_list?channel=2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_jinshicaijing","symbols":["ZTmain","09983","BK1542","TNmain","UBmain","BK1583","ZNmain","BK1258","ZBmain","BK1229","ZFmain"],"gpt_icon":0},{"id":"2517169457","title":"和黃醫藥(00013.HK)HMPL-453治療肝內膽管癌II期臨牀試驗已完成患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2517169457","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517169457?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 23:05","pubTimestamp":1741273500,"startTime":"0","endTime":"0","summary":"和黄医药(00013.HK) 公布，HMPL-453(fanregratinib)用于治疗伴有成纤维细胞生长因子受体2融合/重排的肝内胆管癌患者的II期临床试验已完成患者入组。预计2025年年底左右公布研究的顶线结果。该研究旨在评估HMPL-453用于治疗伴有FGFR2融合/重排的晚期肝内胆管癌患者的疗效、安全性和药代动力学。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-06 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220520173825120_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220520173825120_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1422784/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1588","BK1191","03347","00013","BK1583","BK1576","BK1587","BK1141"],"gpt_icon":0},{"id":"2517116937","title":"百濟神州授出合共3.26萬股受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2517116937","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517116937?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:37","pubTimestamp":1741271821,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨百济神州(06160.HK)公告，于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款向一名承授人授出可认购合共1,100股美国存托股份的购股权并向一百五十一名承授人授出涉及合共32,579股美国存托股份的受限制股份单位。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224232989eb6ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306224232989eb6ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0307460666.USD","06160","LU1969619763.USD","BK1161","LU2328871848.SGD","LU0588546209.SGD","BK1500","BK1588","BK1583"],"gpt_icon":0},{"id":"2517853165","title":"百濟神州(06160)授出購股權及受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2517853165","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517853165?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:15","pubTimestamp":1741270511,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款授予一名承授人可认购合共1100股美国存托股份的购股权。于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款授予151名承授人合共3.26万股美国存托股份受限制股份单位。该等受限制股份单位相当于42.35万股股份，约占本公告之日公司发行股份总数的0.03%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258811.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1500","688235","06160","ONC","BK1588","BK1583","LU2328871848.SGD","BK1161","BK4139","LU0307460666.USD","LU1969619763.USD","LU0588546209.SGD","BK0239"],"gpt_icon":0},{"id":"2517163194","title":"百濟神州(06160.HK)授出合共3.26萬股受限制股份單位","url":"https://stock-news.laohu8.com/highlight/detail?id=2517163194","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517163194?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:12","pubTimestamp":1741270358,"startTime":"0","endTime":"0","summary":"格隆汇3月6日丨百济神州(06160.HK)公告，于2025年3月3日，董事会薪酬委员会根据2016期权及激励计划的条款向一名承授人授出可认购合共1,100股美国存托股份的购股权并向一百五十一名承授人授出涉及合共32,579股美国存托股份的受限制股份单位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/06221248575249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","LU2328871848.SGD","ONC","BK1161","BK1500","LU1969619763.USD","06160","LU0307460666.USD","BK4139","BK1583","BK1588","688235","LU0588546209.SGD"],"gpt_icon":0},{"id":"2517165045","title":"中紅醫療：子公司獲得醫療器械註冊證","url":"https://stock-news.laohu8.com/highlight/detail?id=2517165045","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517165045?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 22:08","pubTimestamp":1741270080,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月6日晚间，中红医疗发布公告称，公司子公司深圳迈德瑞纳生物科技有限公司（简称“迈德瑞纳”）于近期取得了广东省药品监督管理局颁发的《中华人民共和国医疗器械注册证》，迈德瑞纳申报的肠内营养泵医疗器械注册证已审批通过。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-03-06/doc-inenttpc3265800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","BK1574","09997","BK1583","159883","BK1222","BK0220","09996","300981"],"gpt_icon":0}],"pageSize":16,"totalPage":65,"pageCount":16,"totalSize":1027}]}}